Higher Degree by Research Candidate
Adelaide Medical School
Faculty of Health and Medical Sciences
Master of Philosophy (Medical Sciences) Student currently working at SAHMRI (South Australian Health and Medical Research Institute) in the Multiple Myeloma Research Laboratory
Investigation of the competing effects of the CXCR4/CXCL12 and CCR1/CCL3 chemokine axes in the dissemination and migration of Multiple Myeloma Plasma Cells
Date Position Institution name 2016 Master of Philosophy (Medical Sciences) Student University of Adelaide
Awards and Achievements
Date Type Title Institution Name Country Amount 2015 Award RA Fischer Prize in Genetics III — — —
Language Competency German Can read, speak and understand spoken Spanish; Castilian Can read, write, speak and understand spoken
Date Institution name Country Title 2013 - 2015 University of Adelaide Australia Bachelor of Science (Advanced)
Year Citation 2019 Graziani, G., Herget, G., Ihorst, G., Zeissig, M., Chaidos, A., Auner, H., . . . Engelhardt, M. (2019). Time from first symptom onset to the final diagnosis of multiple myeloma (MM)–possible risks and future solutions: retrospective and prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) analysis<sup>*</sup>. Leukemia and Lymphoma.
2017 Vandyke, K., Zeissig, M., Hewett, D., Martin, S., Mrozik, K., Cheong, C., . . . Zannettino, A. (2017). HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1. Cancer Research, 77(20), 5452-5463.
DOI Scopus9 WoS9 Europe PMC3
Year Citation 2017 Zeissig, M. N., Hewett, D. R., Martin, S., Mrozik, K. M., Cheong, C. M., Diamond, P., . . . Zannettino, A. C. (2017). HIF-2 alpha Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY.
Master of Philosophy (No Honours) Scholarship
Connect With Me